BIO-TECHNE Corp — Director's Dealing 2014

Dec 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2014-12-01

Reporting Person: Gavin Robert M. (Sen. VP Protein Platforms)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-01	Stock Option	$90.25	A	5000	Acquired	2021-11-30	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$93.32	2021-07-31	Common Stock (10000)	10000	Direct
Stock Option	$93.32	2021-07-31	Common Stock (50000)	50000	Direct

Footnotes

F1: Includes 5,000 restricted stock units that represent a contingent right to receive one share of Bio-Techne Corporation common stock. The restricted stock units vest if certain performance goals are achieved for calendar 2016.

F2: Vests 2,500 on each of 07/31/2015, 07/31/2016, 07/31/2017, and 07/31/2018.

F3: Includes 50,000 common stock options. The options vest if certain performance goals are achieved for calendar 2016.

F4: Vests 1,250 on each of 12/01/2015, 12/01/2016, 12/01/2017, and 12/01/2018.